Skip to main content

CMS and FDA RAPID: Faster Device Coverage Needs Stronger Evidence Discipline

The new RAPID coverage pathway from the Centers for Medicare and Medicaid Services and the U.S. Food and Drug Administration reflects a long-running frustration in medical technology policy: authorization and coverage are separate decisions, and patients often wait in the gap between the two.

April 28, 2026
Photo 116282449 © Jarretera | Dreamstime.com